Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIstanbul Medipol University Hospital

About this trial

This randomized controlled trial aims to evaluate the effectiveness of topical paraffin oil application in preventing tourniquet-related skin lesions in patients undergoing upper extremity surgery. Pneumatic tourniquets are commonly used to provide a bloodless surgical field; however, they may cause skin complications such as erythema, edema, abrasions, blisters, and burns.

In this study, adult patients undergoing elective upper extremity surgery will be randomly assigned to either an intervention group receiving topical paraffin oil application in addition to routine protective dressing or a control group receiving routine care only. Skin integrity will be assessed immediately after tourniquet removal and at 30 and 60 minutes postoperatively using standardized skin assessment criteria.

The findings of this study are expected to contribute to the development of effective, simple, and cost-efficient strategies to prevent tourniquet-related skin complications and improve patient safety and postoperative comfort.

Eligibility criteria

Qualifiers

Age ≥18 years

Patients scheduled for elective upper extremity surgery requiring pneumatic tourniquet application

ASA physical status I-III

Body mass index (BMI) <30 kg/m²

Disqualifiers

Age <18 years

Known dermatological disease or existing skin lesion at the tourniquet application site

Allergy or sensitivity to paraffin oil or related substances

Severe systemic disease (ASA IV or higher)

Trial design

Treatments tested in this trial

  • Paraffin Oil

Treatment groups

90 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Istanbul Medipol University Hospital

Lead sponsor

Kartal Dr. Lütfi Kirdar City Hospital

Collaborator

Medipol University

Collaborator